26.04.2017 • NewsDede WillamsUmicoreBASF

BASF and Argonne Settle With Umicore

(c) Pierre Desrosiers/Shutterstock
(c) Pierre Desrosiers/Shutterstock

German chemical giant BASF and Chicago, USA-based Argonne National Laboratory have settled out of court their running patent disputes with Belgium’s Umicore. The two companies said they had agreed to license the technology to the Belgian company to make, use, sell, offer to sell, distribute and import nickel-manganese-cobalt (NMC) cathode material for lithium-ion batteries in the US under their US patents.

Action had been pending in the US District Court for the District of Delaware. The parties said, however, they planned to file a petition for rescission of the existing limited exclusion order with the International Trade Commission (ITC).

The lawsuit was brought in spring 2015 by BASF and US partner Argonne, which owns the technology developed with investment aid from the US Department of Energy.  In December 2016, the ITC ruled that Umicore had infringed the patent. As a consequence, the company was to be banned from importing either its batteries containing the specified NMC materials or the materials alone. The Commission found also that Umicore contributed to its customers’ infringement.

In an earlier ruling, the ITC’s Judge Thomas B. Pender had rejected Umicore's arguments that the patents were invalid and unenforceable. In its filing, BASF also claimed that Umicore had sold the technology to third parties, including the US arm of Japan's Makita Corporation.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
08.08.2025 • News

Carbios und Indorama kooperieren bei rPET

Carbios wird recycelte Monomere bereitstellen, die von Indorama Ventures zu Filamenten für die Verstärkung von Reifen des Herstellers Michelin verarbeitet werden.

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.